Category: Pharmaceuticals
Global Pharmaceuticals
-
Restorative Dentistry Market by Product (Diagnostic Instrument, Equipment, Material), Type (Direct, Indirect), Cavity Type, End-Use - Global Forecast 2024-2030
... reach USD 8.80 billion in 2024, at a CAGR 7.63% to reach USD 13.74 billion by 2030. Restorative dentistry focuses on diagnosing, preventing, and treating oral diseases. It encompasses a variety of procedures and products ... Read More
-
Pharmaceutical Marketing Market by Category (Conference Marketing, PPC Advertising, Print Advertising), Distribution (Generic Drug Marketing, Institutional Supply, Online Pharmacies), Business Model - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 46.03 billion in 2024, at a CAGR 12.26% to reach USD 92.55 billion by 2030. The pharmaceutical market, comprising the discovery, development, production, and distribution of a ... Read More
-
RNAi Technology Market Size, Share & Trends Analysis Report By Product & Services (Products, Services), By Application (Drug Discovery & Development, Functional Genomics), By End-use, By Region, And Segment Forecasts, 2024 - 2030
... Market Growth & Trends The global RNAi technology market size is anticipated to reach USD 6.65 billion by 2030 and is growing at a CAGR of 14.6% from 2024 to 2030, according to a new ... Read More
-
Hemoglobin Testing Market by Type (Blood Glucose Testing, Cyanmethemoglobin Method, Hemoglobin Electrophoresis), Technology (Laboratory Testing, Point-of-Care Testing), Operation, Application, End-User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 6.04 billion in 2024, at a CAGR 6.10% to reach USD 8.63 billion by 2030. The hemoglobin testing market comprises various diagnostic products, services, and technologies that healthcare ... Read More
-
Generic Injectables Market by Product (Large Molecule Injectables, Small Molecule Injectables), Type (Cytokines, Insulin, Monoclonal Antibodies), Application, Distribution Channel - Global Forecast 2024-2030
... 2023 and expected to reach USD 36.58 billion in 2024, at a CAGR 10.64% to reach USD 67.22 billion by 2030. Generic injectables are non-branded pharmaceuticals that are administered by injection and have the same ... Read More
-
Respiratory Care Devices Market by Product (Consumables & Accessories, Diagnostic Devices, Monitoring Devices), Indication (Asthma, Chronic Obstructive Pulmonary Disease, Infectious Disease), End-User - Global Forecast 2024-2030
... USD 19.87 billion in 2023 and expected to reach USD 21.08 billion in 2024, at a CAGR 6.39% to reach USD 30.66 billion by 2030. The respiratory care devices market encompasses various medical devices, equipment, ... Read More
-
Wearable Blood Pressure Monitor Market by Measurement (Arterial Tonometry, Oscillometric Method, Pulse Transit Time Method), Use (Arm, Wrist), Component, Indication, Distribution Channel, Application - Global Forecast 2024-2030
... estimated at USD 2.47 billion in 2023 and expected to reach USD 2.87 billion in 2024, at a CAGR 16.19% to reach USD 7.07 billion by 2030. A wearable blood pressure monitor is a technologically ... Read More
-
Sickle Cell Anemia Testing & Screening Market by Technology (Hemoglobin Electrophoresis, High-performance Liquid Chromatography (HPLC), Point-of-Care Tests), Age Group (Adult Screening, Newborn Screening, Years 1 to 25), Sector - Global Forecast 2024-2030
... Anemia Testing & Screening Market size was estimated at USD 943.95 million in 2023 and expected to reach USD 1,070.69 million in 2024, at a CAGR 13.51% to reach USD 2,293.22 million by 2030. Sickle ... Read More
-
Breath Analyzer Market by Technology (Fuel Cell Technology, Infrared & Smart Crystal, Semiconductor Oxide Sensor Technology), Application (Alcohol Detection, Asthma Detection, COVID-19 Test), End User - Global Forecast 2024-2030
... estimated at USD 2.91 billion in 2023 and expected to reach USD 3.15 billion in 2024, at a CAGR 8.42% to reach USD 5.12 billion by 2030. Breath analyzers are analytical devices used to measure ... Read More
-
Botanical Supplements Market by Source (Flower, Fruits, Leaves), Age-Group (0-10 Years, 11-20 Years, 21-45 Years), Form, Application, Distribution Channel - Global Forecast 2024-2030
... 2023 and expected to reach USD 49.16 billion in 2024, at a CAGR 15.69% to reach USD 118.61 billion by 2030. Botanical supplements are nutritional supplements made from plants or plant extracts and are often ... Read More
-
Cannabis-infused Edibles Market by Product (Baked Products, Chocolates & Bars, Drinks), Raw Material (Hemp CBD Oil, Marijuana CBD Oil), Source, Distribution Channel - Global Forecast 2024-2030
... 5.13 billion in 2023 and expected to reach USD 6.00 billion in 2024, at a CAGR 11.64% to reach USD 11.09 billion by 2030. Cannabis-infused edibles are food products infused with cannabinoids, an active compound ... Read More
-
Pulmonary Drugs Market by Drug Class (Anti-Cholinergic Agents, Anti-Leukotrienes, Antihistamines), Indication (Allergic Rhinitis, Asthma, Chronic Obstructive Pulmonary Disease), Drug Type, Distribution Channel, End-User - Global Forecast 2024-2030
... USD 79.35 billion in 2023 and expected to reach USD 86.14 billion in 2024, at a CAGR 8.03% to reach USD 136.27 billion by 2030. The pulmonary drugs market encompasses a wide range of therapeutic ... Read More
-
Artificial Intelligence in Pharmaceutical Market by Offering (Hardware, Services, Software), Technology (Computer Vision, Context-Aware Computing, Machine Learning), Applications, End-users - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 20.76 billion in 2024, at a CAGR 29.18% to reach USD 97.35 billion by 2030. Artificial intelligence (AI) in the pharmaceutical market refers to integrating advanced machine ... Read More
-
Baicalin Market by Form (Extract, Powder), End-use (Nutraceuticals & Dietary Supplements, Pharmaceutical, Skincare & Cosmetics) - Global Forecast 2024-2030
... USD 157.71 million in 2024, at a CAGR 3.42% to reach USD 193.34 million by 2030. Baicalin is a flavone glycoside isolated from the root of Scutellaria baicalensis Georgi, a plant widely used in traditional ... Read More
-
Digital Dose Inhaler Market by Product (Dry Powder Inhalers, Metered Dose Inhalers), Type (Branded Medication, Generics Medication), Distribution Channel, Application - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 1.15 billion in 2024, at a CAGR 10.33% to reach USD 2.08 billion by 2030. The digital dose inhaler market encompasses the sector for medical devices that ... Read More
-
COVID-19 Clinical Trials Market by Product (Therapeutics, Vaccines), Phase (Phase I, Phase II, Phase III) - Global Forecast 2024-2030
... to reach USD 6.79 billion in 2024, at a CAGR 13.93% to reach USD 14.84 billion by 2030. The COVID-19 clinical trials market comprises all research activities and trials to examine the efficacy and safety ... Read More
-
Drug Discovery Market by Drug Type (Biologic Drugs, Small Molecule Drugs), Technology (Bioanalytical Instruments, Biochips, Bioinformatics), Therapeutic Area, End User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 71.12 billion in 2024, at a CAGR 14.10% to reach USD 157.13 billion by 2030. Drug discovery is a multifaceted and intricate process that encompasses the identification of ... Read More
-
Facial Injectables Market by Type (Anti-aging Injections, Dermal Fillers), End User (Beauty Clinics, Dermatology Clinics, Dermatology Research Institutes) - Global Forecast 2024-2030
... and expected to reach USD 19.30 billion in 2024, at a CAGR 11.77% to reach USD 37.72 billion by 2030. Facial injectables are medical treatments administered through injections to enhance facial aesthetics, rejuvenate skin, and ... Read More
-
Laboratory Proficiency Testing Market by Technology (Cell Culture, Chromatography, Immunoassays), Application (Biologics, Cannabis/Opioids, Clinical Diagnostics), End-Use - Global Forecast 2024-2030
... expected to reach USD 2.39 billion in 2024, at a CAGR 7.85% to reach USD 3.77 billion by 2030. Laboratory Proficiency Testing (LPT) is a method used to evaluate and monitor the performance of laboratories ... Read More
-
Mobile Physician Practice Market by Type (Emergency Medicine, Telehealth), Services (Monitoring Services, Pain Management, Palliative Care), End-user - Global Forecast 2024-2030
... and expected to reach USD 4.51 billion in 2024, at a CAGR 6.88% to reach USD 6.76 billion by 2030. Mobile physician practice refers to a healthcare delivery model where medical professionals provide in-person medical ... Read More
-
Vaccines Market by Type (Monovalent Vaccine, Multivalent Vaccine), Technology Type (Inactivated Vaccines, Live-Attenuated Vaccines, Messenger RNA (mRNA) Vaccines), Indication, Route of administration, Age Group - Global Forecast 2024-2030
... USD 55.66 billion in 2023 and expected to reach USD 59.94 billion in 2024, at a CAGR 7.79% to reach USD 94.14 billion by 2030. Vaccines are biological preparations that equip the body's immune system ... Read More
-
Biologics Market by Source (Mammalian, Microbial), Product (Antisense & RNAi Therapeutics, Monoclonal Antibodies, Recombinant Hormones or Proteins), Indication, End-user - Global Forecast 2024-2030
... and expected to reach USD 430.59 billion in 2024, at a CAGR 6.39% to reach USD 626.34 billion by 2030. Biologics are integral to the biomedical sector, focusing on developing, manufacturing, and distributing biological treatments ... Read More
-
Foot & Mouth Disease Vaccines Market by Product (Conventional, Emergency), Type (DNA Vaccines, Inactivated Vaccines, Live Attenuated Vaccines), Application, Distribution Channel - Global Forecast 2024-2030
... at USD 2.69 billion in 2023 and expected to reach USD 2.93 billion in 2024, at a CAGR 9.10% to reach USD 4.95 billion by 2030. Foot and mouth disease vaccines are biologics designed to ... Read More
-
HIV Vaccines Market by Phase (Phase I, Phase II, Phase III), Category (Preventive Vaccines, Therapeutic Vaccines), Antibodies, End Users - Global Forecast 2024-2030
... 2023 and expected to reach USD 940.05 million in 2024, at a CAGR 12.88% to reach USD 1,951.26 million by 2030. The HIV vaccine pertains to the research, development, and commercialization of vaccines that are ... Read More
-
Eprazinone Market by Indication (Bronchial asthma, Chronic / acute cough, Chronic respiratory failure), Product (Liquid, Tablet), Distribution Channel, Mode of Administation - Global Forecast 2024-2030
... in 2023 and expected to reach USD 18.60 billion in 2024, at a CAGR 8.11% to reach USD 29.75 billion by 2030. Eprazinone is a mucolytic and expectorant medication utilized in the treatment of respiratory ... Read More
Research Assistance
